Journal
CLINICAL MICROBIOLOGY AND INFECTION
Volume 28, Issue 9, Pages 1182-1183Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.cmi.2022.05.005
Keywords
Antivirals; COVID-19; Guidelines; Immunocompromised; Trials